Business · 10/10/2023
FDA Revokes Emergency Use Authorizations for Mpox Diagnostic Devices
The FDA has revoked two Emergency Use Authorizations for diagnostic devices to detect Mpox, issued to Life Technologies Corp. and Becton, Dickinson and Co., following a request from the authorization holders.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →
Related company profile: Thermo Fisher ScientificOpen profile →Explore businesses on Business Maps →